Efficacy of Psychosomatic Model of Gastroenterology in Treatment of Functional Gastrointestinal Disorders
10.3969/j.issn.1008-7125.2024.11.001
- VernacularTitle:心身整体胃肠病学模式处置功能性胃肠病的疗效研究
- Author:
Wenrong WANG
1
;
Qiaoli ZHANG
1
;
Qing HOU
1
;
Jianxin CAO
1
;
Lixin DING
1
Author Information
1. 苏州大学附属第三医院心身胃肠病学科 苏州大学心身胃肠病学研究所(213000)
- Publication Type:Journal Article
- Keywords:
Functional Gastrointestinal Disorders;
Psychosomatic Medicine;
Psychosomatic Intervention;
Treatment as Usual;
Patient-Reported Outcomes
- From:
Chinese Journal of Gastroenterology
2024;29(11):641-648
- CountryChina
- Language:Chinese
-
Abstract:
Background:Patients with functional gastrointestinal disorders(FGIDs)often experience stigma related to symptom attribution and psychological interventions.Treatment as usual,including the use of neuromodulators,has shown limited effectiveness.Therefore,there is an urgent need for a comprehensive and individualized psychosomatic approach to effectively manage FGIDs in clinical practice.Aims:To evaluate whether the psychosomatic model of gastroenterology provide superior outcomes in FGIDs management compared with treatment as usual.Methods:A total of 165 FGIDs patients who attended the Department of Gastroenterology at the Third Affiliated Hospital of Soochow University from May 2024 to July 2024 were enrolled and randomly assigned to the treatment as usual group and the psychosomatic gastroenterology treatment group.Patients in treatment as usual group received lifestyle modifications and pharmacotherapy,including neuromodulators,while those in psychosomatic gastroenterology group received the symptom-oriented stepped reattribution model in addition to treatment as usual.After a 4-week intervention,treatment efficacy was assessed based on patient-reported outcomes.Neuromodulators adherence and overall clinical efficacy were compared between the two groups.Results:After 4 weeks of intervention,the effectiveness rates were 51.2％in the treatment as usual group and 85.0％in the psychosomatic gastroenterology group(P＜0.001).Neuromodulators adherence rates were 38.5％in the treatment as usual group and 85.4％in the psychosomatic gastroenterology group(P＜0.001).Patients in the psychosomatic gastroenterology group showed significantly lower scores on the GAD-7,PHQ-9,PHQ-15,and GCBI scales and higher scores on the GIQLI scale compared to the treatment as usual group(all P＜0.05).Conclusions:The psychosomatic model of gastroenterology significantly improves the neuromodulators adherence and the overall clinical efficacy in FGIDs patients compared with treatment as usual.
